hydrogen sulfide has been researched along with Neoplasms in 75 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Accumulating evidence suggests that abnormal levels of homocysteine are associated with vascular dysfunctions, cancer cell proliferation and various neurodegenerative diseases." | 7.83 | Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases. ( Andriamihaja, M; Artaud, I; Blachier, F; Castillo, FT; Galardon, E; Hessani, A; Lan, A; Liot, G; Padovani, D; Pilati, C; Sen, S, 2016) |
| "Hyperhomocysteinemia/Homocysteinuria is characterized by an increased level of toxic homocysteine in the plasma." | 5.01 | Disturbed homocysteine metabolism is associated with cancer. ( Arora, R; Bansal, AK; Bhattacharya, R; Hasan, T; Sharma, GS; Singh, LR, 2019) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Accumulating evidence suggests that abnormal levels of homocysteine are associated with vascular dysfunctions, cancer cell proliferation and various neurodegenerative diseases." | 3.83 | Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases. ( Andriamihaja, M; Artaud, I; Blachier, F; Castillo, FT; Galardon, E; Hessani, A; Lan, A; Liot, G; Padovani, D; Pilati, C; Sen, S, 2016) |
| "They can stimulate or inhibit cancer cell proliferation and invasion, as well as interfere with cancer cell responses to drug treatments." | 2.82 | Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review). ( Abdullah, RM; Al-Naqshabandi, MA; Alkasalias, T; Hama, HA; Housein, Z; Hussen, BM; Khudhur, ZO; Salihi, A, 2022) |
| "The preventable nature of cancer and the importance of a complex multi-level approach in anticancer therapy motivate the search for novel avenues of establishing the anticancer environment in the human body." | 2.72 | Postbiotics, Metabolic Signaling, and Cancer. ( Ruml, T; Vrzáčková, N; Zelenka, J, 2021) |
| "Though historically known as a toxic gas, hydrogen sulfide (H₂S) has displayed a new face as the third endogenous gaseous signaling molecule after nitric oxide (NO) and carbon monoxide (CO)." | 2.61 | Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity. ( Bian, J; Cao, X; Moore, PK; Zhang, W, 2019) |
| "Assays that could aid in cancer diagnostics, assessing anticancer drug resistance, and in the discovery of new anticancer drugs are highly warranted." | 2.58 | Fluorescent Chemosensors as Future Tools for Cancer Biology. ( Beharry, AA; Rotaru, AM; Singh, K, 2018) |
| "This is particularly evident in cancers of the colon and ovaries, where the malignant cells both overexpress cystathionine-β-synthase (CBS) and produce increased amounts of H2S, which enhances tumor growth and spread by (a) stimulating cellular bioenergetics, (b) activating proliferative, migratory, and invasive signaling pathways, and (c) enhancing tumor angiogenesis." | 2.52 | Hydrogen Sulfide and Cancer. ( Hellmich, MR; Szabo, C, 2015) |
| "In addition to promoting cancer cell death, H2S donors were also found to inhibit cancer angiogenesis and metastasis." | 2.52 | Role of H2S Donors in Cancer Biology. ( Deng, LW; Lee, ZW, 2015) |
| " sepsis), while in other disease states H2 S levels and H2 S bioavailability are reduced and its therapeutic replacement is warranted (e." | 2.50 | Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. ( Bos, EM; Bouillaud, F; Calzia, E; Coletta, C; Hellmich, MR; Módis, K; Papapetropoulos, A; Radermacher, P; Szabo, C; van Goor, H, 2014) |
| "Hydrogen sulfide, H2S, is a colorless gas with a strong odor that until recently was only considered to be a toxic environmental pollutant with little or no physiological significance." | 2.49 | Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. ( Kashfi, K; Olson, KR, 2013) |
| "Carbon monoxide (CO) is a gaseous product generated by heme oxygenase (HO), which oxidatively degrades heme." | 2.48 | Carbon monoxide: impact on remethylation/transsulfuration metabolism and its pathophysiologic implications. ( Hishiki, T; Kajimura, M; Kubo, A; Morikawa, T; Suematsu, M; Yamamoto, T, 2012) |
| "Imaging cancer specific biomarkers with near-infrared (NIR) fluorescent probes can help inaccurate diagnosis." | 1.91 | A biotin-guided near-infrared fluorescent probe for imaging hydrogen sulfide and differentiating cancer cells. ( Cai, X; Dong, Y; Hao, T; Yang, X; Yi, L; Zhang, Z, 2023) |
| "However, how MR impacts cancer progression in the context of the intact immune system is unknown." | 1.91 | Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota. ( Anantharaman, K; Andrea Azcarate-Peril, M; Arbeev, KG; Garcia-Peterson, LM; Hsiao, YC; Ji, M; Li, JL; Li, X; Liu, J; Lu, K; Martin, C; Popov, V; Randall, TA; Shats, I; Ukraintseva, S; Wan, Y; Wu, X; Xu, Q; Xu, X; Yashin, AI, 2023) |
| "Discovering and monitoring cancer markers are the main methods for early diagnosis of cancer." | 1.62 | Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH. ( Fei, J; Jiang, WL; Li, CY; Li, Y; Mao, GJ; She, ZP; Wang, WX; Wang, ZQ, 2021) |
| "Therefore, an anticancer balance between pathological and protective immune response is urgently needed for an advanced photothermal therapeutic tactic." | 1.62 | Engineering a Hydrogen-Sulfide-Based Nanomodulator to Normalize Hyperactive Photothermal Immunogenicity for Combination Cancer Therapy. ( Dai, Y; Fan, Q; Li, B; Li, J; Li, W; Sang, W; Tian, H; Wang, G; Xie, L; Yin, C; Zhang, X; Zhang, Z, 2021) |
| "Gas-involving cancer theranostics have attracted considerable attention in recent years due to their high therapeutic efficacy and biosafety." | 1.51 | Gas-Mediated Cancer Bioimaging and Therapy. ( Chen, L; Song, J; Su, L; Zhou, SF, 2019) |
| "In addition, it has been reported that cancer cells can produce large amounts of hydrogen sulfide (H2S) and their survival depends on the content of H2S." | 1.43 | Hydrogen Sulfide Triggered Charge-Reversal Micelles for Cancer-Targeted Drug Delivery and Imaging. ( Kong, X; Lin, W; Tang, Y; Zhang, H, 2016) |
| "Hydrogen sulfide (H2S) has emerged as an exciting endogenous gasotransmitter in addition to nitric oxide and carbon monoxide." | 1.42 | Visualization of in Vivo Hydrogen Sulfide Production by a Bioluminescence Probe in Cancer Cells and Nude Mice. ( Lau, C; Li, Z; Lu, J; Tian, X, 2015) |
| "Cancer and non-cancer cells were exposed to H2 S [using sodium hydrosulfide (NaHS) and GYY4137] and cell viability was examined by crystal violet assay." | 1.40 | Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance. ( Deng, LW; Hagen, T; Lee, ZW; Moore, PK; Tan, CH; Tay, EY; Teo, XY, 2014) |
| "To determine colorectal and overall cancer incidence as part of a three-pronged investigation in response to the concerns of a First Nations community in Alberta, Canada, located close to sulfur-rich natural gas installations, and to determine whether the incidence of cancers observed in this reserve was higher than expected." | 1.36 | An investigation of cancer incidence in a First Nations community in Alberta, Canada, 1995-2006. ( Ashbury, F; Chen, Y; Colquhoun, A; Drobina, W; Jiang, Z; Maiangowi, G; McLeod, L; Panaro, L; Sihota, S; Tustin, J; Yacoub, W, 2010) |
| "To assess mortality and cancer morbidity in Canadian petroleum workers and explore exposure-response relations for specific petroleum agents." | 1.32 | Mortality and cancer morbidity in a cohort of Canadian petroleum workers. ( Dahlman, D; Drummond, I; Jorgensen, G; Katz, AM; Lewis, RJ; Murray, N; Nicolich, MJ; Schnatter, AR; Thériault, G; Thompson, FS, 2003) |
| "Of the cancer sites, there was an elevated rate for nasal cancers." | 1.30 | Cancer incidence, morbidity and geothermal air pollution in Rotorua, New Zealand. ( Bates, MN; Garrett, N; Graham, B; Read, D, 1998) |
| "The incident cancers during this period were enumerated by computerized record linkage with the Alberta Cancer Registry." | 1.28 | Cancer downwind from sour gas refineries: the perception and the reality of an epidemic. ( Dales, RE; Eastridge, LM; Hobbs, C; Hutcheon, ME; Schechter, MT; Spitzer, WO; Steinmetz, N; Tousignant, P, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.00) | 18.7374 |
| 1990's | 2 (2.67) | 18.2507 |
| 2000's | 3 (4.00) | 29.6817 |
| 2010's | 34 (45.33) | 24.3611 |
| 2020's | 33 (44.00) | 2.80 |
| Authors | Studies |
|---|---|
| She, ZP | 1 |
| Wang, WX | 2 |
| Jiang, WL | 1 |
| Wang, ZQ | 2 |
| Mao, GJ | 2 |
| Fei, J | 1 |
| Li, Y | 3 |
| Li, CY | 2 |
| Jing, YZ | 1 |
| Li, SJ | 1 |
| Sun, ZJ | 1 |
| Ding, H | 1 |
| Chang, J | 1 |
| He, F | 2 |
| Gai, S | 2 |
| Yang, P | 3 |
| Liu, R | 1 |
| Peng, Y | 1 |
| Lu, L | 1 |
| Peng, S | 1 |
| Chen, T | 1 |
| Zhan, M | 1 |
| Yuan, J | 1 |
| Ren, TB | 1 |
| Xu, S | 1 |
| Wang, CJ | 1 |
| Zhang, XB | 1 |
| Yuan, L | 1 |
| Xiong, J | 1 |
| Wang, Y | 2 |
| Jiang, X | 1 |
| Liang, X | 1 |
| Liang, Q | 1 |
| Li, J | 3 |
| Xie, L | 2 |
| Sang, W | 2 |
| Li, W | 2 |
| Wang, G | 2 |
| Yan, J | 1 |
| Zhang, Z | 3 |
| Tian, H | 2 |
| Fan, Q | 2 |
| Dai, Y | 2 |
| Salihi, A | 1 |
| Al-Naqshabandi, MA | 1 |
| Khudhur, ZO | 1 |
| Housein, Z | 1 |
| Hama, HA | 1 |
| Abdullah, RM | 1 |
| Hussen, BM | 1 |
| Alkasalias, T | 1 |
| Tan, ZK | 1 |
| Chen, DH | 1 |
| Khattak, S | 1 |
| Rauf, MA | 1 |
| Khan, NH | 1 |
| Zhang, QQ | 1 |
| Chen, HJ | 2 |
| Muhammad, P | 1 |
| Ansari, MA | 1 |
| Alomary, MN | 1 |
| Jahangir, M | 1 |
| Zhang, CY | 1 |
| Ji, XY | 2 |
| Wu, DD | 2 |
| Fan, Y | 1 |
| Tan, X | 1 |
| Zhao, H | 1 |
| Tu, X | 1 |
| Liu, X | 2 |
| Li, G | 1 |
| Lei, H | 1 |
| Yang, Y | 2 |
| Zhong, X | 1 |
| Gong, F | 1 |
| Gong, Y | 1 |
| Zhou, Y | 1 |
| Zhang, Y | 1 |
| Shi, H | 1 |
| Xiao, Z | 1 |
| Dong, Z | 1 |
| Cheng, L | 1 |
| van der Vlies, AJ | 2 |
| Ghasemi, M | 2 |
| Adair, BM | 2 |
| Adair, JH | 2 |
| Gomez, ED | 2 |
| Hasegawa, U | 2 |
| Cai, X | 1 |
| Dong, Y | 1 |
| Hao, T | 1 |
| Yi, L | 1 |
| Yang, X | 1 |
| Faris, P | 1 |
| Negri, S | 1 |
| Faris, D | 1 |
| Scolari, F | 1 |
| Montagna, D | 1 |
| Moccia, F | 1 |
| Kafuti, YS | 1 |
| Zeng, S | 1 |
| Han, J | 1 |
| Qian, M | 1 |
| Chen, Q | 2 |
| Wang, J | 1 |
| Peng, X | 2 |
| Yoon, J | 1 |
| Li, H | 1 |
| Li, K | 1 |
| Qin, YZ | 1 |
| Zhou, JJ | 1 |
| Li, T | 1 |
| Qian, L | 1 |
| Yang, CY | 1 |
| Oza, PP | 1 |
| Kashfi, K | 6 |
| Ji, M | 1 |
| Xu, X | 2 |
| Xu, Q | 1 |
| Hsiao, YC | 1 |
| Martin, C | 1 |
| Ukraintseva, S | 1 |
| Popov, V | 1 |
| Arbeev, KG | 1 |
| Randall, TA | 1 |
| Wu, X | 1 |
| Garcia-Peterson, LM | 1 |
| Liu, J | 1 |
| Andrea Azcarate-Peril, M | 1 |
| Wan, Y | 1 |
| Yashin, AI | 1 |
| Anantharaman, K | 1 |
| Lu, K | 1 |
| Li, JL | 1 |
| Shats, I | 1 |
| Li, X | 2 |
| Chen, HY | 2 |
| Xu, HB | 1 |
| Lv, J | 1 |
| Chang, S | 1 |
| Wu, MS | 1 |
| Chen, ZC | 1 |
| Zhu, SC | 1 |
| He, Y | 1 |
| Qian, RC | 1 |
| Li, DW | 1 |
| Citi, V | 1 |
| Barresi, E | 1 |
| Piragine, E | 1 |
| Spezzini, J | 1 |
| Testai, L | 1 |
| Da Settimo, F | 1 |
| Martelli, A | 1 |
| Taliani, S | 1 |
| Calderone, V | 1 |
| An, L | 1 |
| Lin, J | 3 |
| Tian, Q | 1 |
| Yang, S | 1 |
| Chen, L | 1 |
| Zhou, SF | 1 |
| Su, L | 1 |
| Song, J | 1 |
| Liu, Y | 1 |
| Chen, H | 1 |
| Cai, Y | 1 |
| Sheng, T | 1 |
| Wang, P | 1 |
| Li, Z | 2 |
| Yang, F | 1 |
| Gu, N | 1 |
| He, T | 1 |
| Qin, X | 1 |
| Jiang, C | 1 |
| Jiang, D | 1 |
| Lei, S | 1 |
| Zhu, WG | 1 |
| Qu, J | 1 |
| Huang, P | 1 |
| Zuhra, K | 2 |
| Augsburger, F | 1 |
| Majtan, T | 1 |
| Szabo, C | 5 |
| Zheng, Z | 1 |
| Dai, R | 1 |
| Jia, Z | 1 |
| Yang, C | 1 |
| Zhang, R | 1 |
| Tomé, CS | 1 |
| Forte, E | 1 |
| Vicente, JB | 2 |
| Giuffrè, A | 1 |
| Bonifácio, VDB | 1 |
| Pereira, SA | 1 |
| Serpa, J | 1 |
| Vrzáčková, N | 1 |
| Ruml, T | 1 |
| Zelenka, J | 1 |
| Li, B | 1 |
| Yin, C | 1 |
| Zhang, X | 1 |
| Liu, B | 1 |
| Liang, S | 1 |
| Wang, Z | 2 |
| Sun, Q | 1 |
| Cheng, Z | 1 |
| Wang, RH | 1 |
| Chu, YH | 1 |
| Lin, KT | 1 |
| Velusamy, N | 1 |
| Binoy, A | 1 |
| Bobba, KN | 1 |
| Nedungadi, D | 1 |
| Mishra, N | 1 |
| Bhuniya, S | 1 |
| Ma, Y | 2 |
| Li, A | 1 |
| Zhang, C | 1 |
| Tang, B | 1 |
| Singh, K | 1 |
| Rotaru, AM | 1 |
| Beharry, AA | 1 |
| Ansari, MI | 1 |
| Khan, MM | 1 |
| Saquib, M | 1 |
| Khatoon, S | 1 |
| Hussain, MK | 1 |
| Cao, X | 2 |
| Ding, L | 1 |
| Xie, ZZ | 1 |
| Whiteman, M | 1 |
| Moore, PK | 3 |
| Bian, JS | 1 |
| Zhu, H | 1 |
| Blake, S | 1 |
| Chan, KT | 1 |
| Pearson, RB | 1 |
| Kang, J | 1 |
| Wu, L | 1 |
| Sun, Y | 1 |
| Sugimoto, K | 1 |
| Luo, Z | 1 |
| Ishigaki, Y | 1 |
| Pu, K | 1 |
| Suzuki, T | 1 |
| Ye, D | 1 |
| Zhang, W | 1 |
| Bian, J | 1 |
| Hasan, T | 1 |
| Arora, R | 1 |
| Bansal, AK | 1 |
| Bhattacharya, R | 1 |
| Sharma, GS | 1 |
| Singh, LR | 1 |
| Wang, H | 1 |
| Su, S | 1 |
| Chen, Y | 2 |
| Wang, X | 1 |
| Módis, K | 1 |
| Bos, EM | 1 |
| Calzia, E | 1 |
| van Goor, H | 1 |
| Coletta, C | 1 |
| Papapetropoulos, A | 1 |
| Hellmich, MR | 2 |
| Radermacher, P | 1 |
| Bouillaud, F | 1 |
| Song, P | 1 |
| Zou, MH | 1 |
| Lee, ZW | 2 |
| Teo, XY | 1 |
| Tay, EY | 1 |
| Tan, CH | 1 |
| Hagen, T | 1 |
| Deng, LW | 2 |
| Lewis, RJ | 2 |
| Copley, GB | 1 |
| Bełtowski, J | 1 |
| Tian, X | 1 |
| Lau, C | 1 |
| Lu, J | 1 |
| De Preter, G | 1 |
| Deriemaeker, C | 1 |
| Danhier, P | 1 |
| Brisson, L | 1 |
| Cao Pham, TT | 1 |
| Grégoire, V | 1 |
| Jordan, BF | 1 |
| Sonveaux, P | 1 |
| Gallez, B | 1 |
| Zhang, H | 1 |
| Kong, X | 1 |
| Tang, Y | 1 |
| Lin, W | 1 |
| Wu, Z | 1 |
| Liang, D | 1 |
| Tang, X | 1 |
| Ciocci, M | 1 |
| Iorio, E | 1 |
| Carotenuto, F | 1 |
| Khashoggi, HA | 1 |
| Nanni, F | 1 |
| Melino, S | 1 |
| Padovani, D | 1 |
| Hessani, A | 1 |
| Castillo, FT | 1 |
| Liot, G | 1 |
| Andriamihaja, M | 1 |
| Lan, A | 1 |
| Pilati, C | 1 |
| Blachier, F | 1 |
| Sen, S | 1 |
| Galardon, E | 1 |
| Artaud, I | 1 |
| Stroot, PG | 1 |
| Miller, TW | 1 |
| Isenberg, JS | 1 |
| Roberts, DD | 1 |
| Colquhoun, A | 1 |
| Jiang, Z | 1 |
| Maiangowi, G | 2 |
| Ashbury, F | 2 |
| Drobina, W | 1 |
| McLeod, L | 1 |
| Panaro, L | 1 |
| Sihota, S | 1 |
| Tustin, J | 1 |
| Yacoub, W | 1 |
| Chattopadhyay, M | 1 |
| Kodela, R | 1 |
| Nath, N | 1 |
| Street, CR | 1 |
| Velázquez-Martínez, CA | 1 |
| Boring, D | 1 |
| Hishiki, T | 1 |
| Yamamoto, T | 1 |
| Morikawa, T | 1 |
| Kubo, A | 1 |
| Kajimura, M | 1 |
| Suematsu, M | 1 |
| Olson, KR | 1 |
| BARTH, G | 2 |
| GRAEBNER, H | 2 |
| Schnatter, AR | 1 |
| Drummond, I | 1 |
| Murray, N | 1 |
| Thompson, FS | 1 |
| Katz, AM | 1 |
| Jorgensen, G | 1 |
| Nicolich, MJ | 1 |
| Dahlman, D | 1 |
| Thériault, G | 1 |
| Hansson, SO | 1 |
| Bates, MN | 1 |
| Garrett, N | 1 |
| Graham, B | 1 |
| Read, D | 1 |
| Strickland, JA | 1 |
| Foureman, GL | 1 |
| Schechter, MT | 1 |
| Spitzer, WO | 1 |
| Hutcheon, ME | 1 |
| Dales, RE | 1 |
| Eastridge, LM | 1 |
| Steinmetz, N | 1 |
| Tousignant, P | 1 |
| Hobbs, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock[NCT03783091] | Phase 2 | 20 participants (Anticipated) | Interventional | 2019-08-05 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
31 reviews available for hydrogen sulfide and Neoplasms
| Article | Year |
|---|---|
Gas and gas-generating nanoplatforms in cancer therapy.
Topics: Antineoplastic Agents; Carbon Monoxide; Gases; Humans; Hydrogen; Hydrogen Sulfide; Mitochondria; Nan | 2021 |
Hydrogen Sulfide: An Emerging Precision Strategy for Gas Therapy.
Topics: Humans; Hydrogen Sulfide; Nanomedicine; Nanostructures; Neoplasms; Signal Transduction | 2022 |
Near-infrared light-triggered nano-prodrug for cancer gas therapy.
Topics: Animals; Gases; Humans; Hydrogen Sulfide; Infrared Rays; Nanostructures; Neoplasms; Nitric Oxide; Ph | 2021 |
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).
Topics: Carbon Monoxide; Gasotransmitters; Humans; Hydrogen Sulfide; Neoplasms; Nitric Oxide; Prospective St | 2022 |
Hydrogen Sulfide Biology and Its Role in Cancer.
Topics: Animals; Biology; Cysteine; Hydrogen Sulfide; Mammals; Neoplasms; Signal Transduction | 2022 |
Cysteine Metabolism in Tumor Redox Homeostasis.
Topics: Cysteine; Glutathione; Homeostasis; Humans; Hydrogen Sulfide; Neoplasms; Oxidation-Reduction; Qualit | 2023 |
Recent advances in the role of endogenous hydrogen sulphide in cancer cells.
Topics: Energy Metabolism; Humans; Hydrogen Sulfide; Neoplasms | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
The Triple Crown: NO, CO, and H
Topics: Carbon Monoxide; Gasotransmitters; Humans; Hydrogen Sulfide; Neoplasms; Nitric Oxide | 2023 |
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H
Topics: Glutathione; Humans; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Nanomedicine; | 2019 |
Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.
Topics: Animals; Cystathionine beta-Synthase; Down Syndrome; Enzyme Inhibitors; Humans; Hydrogen Sulfide; Ne | 2020 |
The multifaceted roles of sulfane sulfur species in cancer-associated processes.
Topics: Energy Metabolism; Humans; Hydrogen Sulfide; Neoplasms; Sulfur | 2021 |
Cysteine metabolic circuitries: druggable targets in cancer.
Topics: Animals; Cysteine; Energy Metabolism; Epigenesis, Genetic; Glycolysis; Humans; Hydrogen Sulfide; Met | 2021 |
Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells.
Topics: Animals; DNA Repair; DNA, Mitochondrial; Humans; Hydrogen Sulfide; Mitochondria; Mitochondrial Dynam | 2021 |
Postbiotics, Metabolic Signaling, and Cancer.
Topics: beta-Glucans; Butyrates; Dietary Supplements; Fatty Acids, Volatile; Gastrointestinal Microbiome; Hu | 2021 |
The Hidden Role of Hydrogen Sulfide Metabolism in Cancer.
Topics: Animals; Humans; Hydrogen Sulfide; Neoplasms; Signal Transduction | 2021 |
Fluorescent Chemosensors as Future Tools for Cancer Biology.
Topics: Biology; Cell Line, Tumor; Enzymes; Fluorescent Dyes; Glutathione; High-Throughput Screening Assays; | 2018 |
Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemoprevention.
Topics: Anticarcinogenic Agents; Drug Design; Humans; Hydrogen Sulfide; Neoplasms; NF-E2-Related Factor 2; N | 2018 |
Cystathionine
Topics: Carcinogenesis; Colon; Cystathionine beta-Synthase; Female; Humans; Hydrogen Sulfide; Neoplasms; Ova | 2018 |
Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity.
Topics: Cisplatin; Cystathionine gamma-Lyase; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Sulfi | 2019 |
Disturbed homocysteine metabolism is associated with cancer.
Topics: Alleles; Animals; Cystathionine beta-Synthase; Disease Susceptibility; Folic Acid; Genetic Predispos | 2019 |
Anti-cancer activity of new designer hydrogen sulfide-donating hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Drug Scre | 2014 |
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.
Topics: Animals; Diabetes Complications; Energy Metabolism; Gasotransmitters; Hibernation; Humans; Hydrogen | 2014 |
Chronic low-level hydrogen sulfide exposure and potential effects on human health: a review of the epidemiological evidence.
Topics: Air Pollutants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Epidemiological Monitorin | 2015 |
Hydrogen sulfide in pharmacology and medicine--An update.
Topics: Animals; Humans; Hydrogen Sulfide; Mitochondria; Neoplasms; Reperfusion Injury; Signal Transduction | 2015 |
Hydrogen Sulfide and Cancer.
Topics: Cell Proliferation; Humans; Hydrogen Sulfide; Neoplasms | 2015 |
Role of H2S Donors in Cancer Biology.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Humans; Hydrogen Sulfide; Neoplas | 2015 |
Gasotransmitters in cancer: from pathophysiology to experimental therapy.
Topics: Animals; Antineoplastic Agents; Carbon Monoxide; Gasotransmitters; Humans; Hydrogen Sulfide; Neoplas | 2016 |
Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Carbon Monoxide; Humans; Hydrogen Peroxide; H | 2009 |
Carbon monoxide: impact on remethylation/transsulfuration metabolism and its pathophysiologic implications.
Topics: Carbon Monoxide; Cystathionine beta-Synthase; Heme Oxygenase (Decyclizing); Humans; Hydrogen Sulfide | 2012 |
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Chimera; Humans; Hydrogen Sulfide | 2013 |
1 trial available for hydrogen sulfide and Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
44 other studies available for hydrogen sulfide and Neoplasms
| Article | Year |
|---|---|
Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH.
Topics: Animals; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Hydrogen-Ion Concentration; Mice; M | 2021 |
A Unique Multifunctional Luminescent Probe for Self-Monitoring Photodynamic Therapy by Detecting H
Topics: Fluorescent Dyes; Hydrogen Sulfide; Luminescence; Neoplasms; Photochemotherapy; Reactive Oxygen Spec | 2021 |
Kinetically Orthogonal Probe for Simultaneous Measurement of H
Topics: Cell Count; Fluorescent Dyes; Humans; Hydrogen Sulfide; Neoplasms; Nitroreductases | 2022 |
A Metal-Phenolic Nanosensitizer Performs Hydrogen Sulfide-Reprogrammed Oxygen Metabolism for Cancer Radiotherapy Intensification and Immunogenicity.
Topics: Hafnium; Humans; Hydrogen Sulfide; Neoplasms; Oxygen; Polymers | 2022 |
A nitrobenzoxadiazole-based near-infrared fluorescent probe for the specific imaging of H
Topics: Animals; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Mice; Neoplasms; Optical Imaging; Z | 2022 |
Titanium Sulfide Nanosheets Serve as Cascade Bioreactors for H
Topics: Adenosine Triphosphate; Bioreactors; Humans; Hydrogen Sulfide; Neoplasms; Reactive Oxygen Species | 2022 |
Reactive Oxygen Species-Triggered Hydrogen Sulfide Release and Cancer-Selective Antiproliferative Effect of Anethole Dithiolethione-Containing Polymeric Micelles.
Topics: Endothelial Cells; Humans; Hydrogen Sulfide; Micelles; Neoplasms; Polymers; Reactive Oxygen Species | 2023 |
Reactive Oxygen Species-Triggered Hydrogen Sulfide Release and Cancer-Selective Antiproliferative Effect of Anethole Dithiolethione-Containing Polymeric Micelles.
Topics: Endothelial Cells; Humans; Hydrogen Sulfide; Micelles; Neoplasms; Polymers; Reactive Oxygen Species | 2023 |
Reactive Oxygen Species-Triggered Hydrogen Sulfide Release and Cancer-Selective Antiproliferative Effect of Anethole Dithiolethione-Containing Polymeric Micelles.
Topics: Endothelial Cells; Humans; Hydrogen Sulfide; Micelles; Neoplasms; Polymers; Reactive Oxygen Species | 2023 |
Reactive Oxygen Species-Triggered Hydrogen Sulfide Release and Cancer-Selective Antiproliferative Effect of Anethole Dithiolethione-Containing Polymeric Micelles.
Topics: Endothelial Cells; Humans; Hydrogen Sulfide; Micelles; Neoplasms; Polymers; Reactive Oxygen Species | 2023 |
A biotin-guided near-infrared fluorescent probe for imaging hydrogen sulfide and differentiating cancer cells.
Topics: Biotin; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Neoplasms; Optical Imaging | 2023 |
Hydrogen Sulfide (H
Topics: Animals; Humans; Hydrogen Sulfide; Mammals; Neoplasms; Prodrugs; Signal Transduction | 2023 |
Observing hydrogen sulfide in the endoplasmic reticulum of cancer cells and zebrafish by using an activity-based fluorescent probe.
Topics: Animals; Endoplasmic Reticulum; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Neoplasms; S | 2023 |
Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota.
Topics: Animals; Female; Gastrointestinal Microbiome; Hydrogen Sulfide; Male; Methionine; Mice; Neoplasms; R | 2023 |
Smart Nanoplatform for Visualizing Hydrogen Sulfide and Amplifying Oxidative Stress to Tumor Apoptosis.
Topics: Doxorubicin; Humans; Hydrogen Sulfide; Nanoparticles; Neoplasms; Oxidative Stress; Tumor Microenviro | 2023 |
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H
Topics: Cell Line; Diabetes Mellitus, Type 2; Humans; Hydrogen Sulfide; Isothiocyanates; Metformin; Neoplasm | 2023 |
Gas-Mediated Cancer Bioimaging and Therapy.
Topics: Carbon Dioxide; Carbon Monoxide; Gases; Humans; Hydrogen; Hydrogen Sulfide; Neoplasms; Nitric Oxide; | 2019 |
Magnet-activatable nanoliposomes as intracellular bubble microreactors to enhance drug delivery efficacy and burst cancer cells.
Topics: Anethole Trithione; Hep G2 Cells; Humans; Hydrogen Sulfide; Liposomes; Magnetic Fields; Magnetic Res | 2019 |
Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Gases; Hyd | 2020 |
Nitric oxide in cancer and beyond.
Topics: Congresses as Topic; Humans; Hydrogen Sulfide; Neoplasms; Nitric Oxide; Nitric Oxide Synthase Type I | 2020 |
A continuous stimuli-responsive system for NIR-II fluorescence/photoacoustic imaging guided photothermal/gas synergistic therapy.
Topics: Allyl Compounds; Azides; Bismuth; Gases; Hydrogen Sulfide; Nanoparticles; Neoplasms; Optical Imaging | 2020 |
Engineering a Hydrogen-Sulfide-Based Nanomodulator to Normalize Hyperactive Photothermal Immunogenicity for Combination Cancer Therapy.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Hydrogen Sulfide; Neoplasms | 2021 |
A Tumor-Microenvironment-Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal-Enhanced Enzyme Dynamic Therapy.
Topics: Animals; Chloride Peroxidase; Drug Carriers; Drug Liberation; Enzyme Activation; Female; Glutathione | 2021 |
A bioorthogonal fluorescent probe for mitochondrial hydrogen sulfide: new strategy for cancer cell labeling.
Topics: Cell Line, Tumor; Cell Tracking; Coumarins; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; | 2017 |
H
Topics: Animals; Cell Line, Tumor; HCT116 Cells; Hep G2 Cells; Humans; Hydrogen Sulfide; Metalloporphyrins; | 2017 |
The role of hydrogen sulfide in health and disease.
Topics: Carbon Monoxide; Diabetes Mellitus; Gasotransmitters; Gastrointestinal Diseases; Gene Expression Reg | 2018 |
A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?
Topics: Animals; Biosynthetic Pathways; Cell Survival; Cystathionine beta-Synthase; Cystathionine gamma-Lyas | 2019 |
Engineering of Electrochromic Materials as Activatable Probes for Molecular Imaging and Photodynamic Therapy.
Topics: Aniline Compounds; Animals; Cell Line, Tumor; Drug Design; Female; Fluorescent Dyes; HEK293 Cells; H | 2018 |
A red mitochondria-targeted AIEgen for visualizing H
Topics: Animals; Drug Stability; Fluorescent Dyes; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen | 2019 |
Redox regulation of endothelial cell fate.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Cell Cycle; Cell Movement; Cell Transdifferentiation; C | 2014 |
Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Glucose; Glycolysis; Humans; Hydr | 2014 |
Visualization of in Vivo Hydrogen Sulfide Production by a Bioluminescence Probe in Cancer Cells and Nude Mice.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Firefly Luciferin; Human | 2015 |
A Fast Hydrogen Sulfide-Releasing Donor Increases the Tumor Response to Radiotherapy.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Femal | 2016 |
Hydrogen Sulfide Triggered Charge-Reversal Micelles for Cancer-Targeted Drug Delivery and Imaging.
Topics: Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen Sulfi | 2016 |
Visualizing Hydrogen Sulfide in Mitochondria and Lysosome of Living Cells and in Tumors of Living Mice with Positively Charged Fluorescent Chemosensors.
Topics: Animals; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Lysosomes; Mice; Mice, Nude; Micros | 2016 |
H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair.
Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Cardiotonic Agents; Cell Cycle; Cell Line, Tumor; | 2016 |
Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases.
Topics: Animals; Catalase; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Activation; Heme; | 2016 |
Blood oxidative stress (BLOS) is a secondary host defense system responding normally to anaerobic wound infection and inadvertently to dietary ultra-exogenous sulfide formation (USF).
Topics: Anaerobiosis; Animals; Atherosclerosis; Bacterial Infections; Blood Component Removal; Blood Glucose | 2017 |
An investigation of cancer incidence in a First Nations community in Alberta, Canada, 1995-2006.
Topics: Adolescent; Adult; Alberta; Child; Child, Preschool; Colorectal Neoplasms; Environmental Exposure; F | 2010 |
Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Topics: Animals; Aspirin; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP1A1; Gene Expression Reg | 2012 |
[Observation on the formation of hydrogen sulfide in tumor irradiation. I].
Topics: Hydrogen Sulfide; Neoplasms; Radiation Effects | 1962 |
[HYDROGEN SULFIDE DEVELOPMENT DURING TUMOR IRRADIATION. II. ATTEMPTED ALTERATION OF H2S FORMATION BY PARATUMORAL RUTIN THERAPY].
Topics: Animals; Hydrogen Sulfide; Hydrogen-Ion Concentration; Metabolism; Mice; Neoplasm Proteins; Neoplasm | 1963 |
Mortality and cancer morbidity in a cohort of Canadian petroleum workers.
Topics: Adult; Canada; Cause of Death; Cohort Studies; Extraction and Processing Industry; Female; Humans; H | 2003 |
Critical effects and exposure limits.
Topics: Acetone; Allergens; Animals; Caprolactam; Carcinogens; Central Nervous System Diseases; Dose-Respons | 1997 |
Cancer incidence, morbidity and geothermal air pollution in Rotorua, New Zealand.
Topics: Air Pollutants; Confidence Intervals; Ear Neoplasms; Ear, Middle; Ecology; Energy-Generating Resourc | 1998 |
US EPA's acute reference exposure methodology for acute inhalation exposures.
Topics: Air Pollutants; Humans; Hydrocarbons, Chlorinated; Hydrogen Sulfide; Inhalation Exposure; Models, Th | 2002 |
Cancer downwind from sour gas refineries: the perception and the reality of an epidemic.
Topics: Acid Rain; Adult; Aged; Air Pollutants; Alberta; Cohort Studies; Cross-Sectional Studies; Female; Hu | 1989 |